hospitals

Clinical Trial Ethics

Industry Insights from Paul Meade, M. Sc, MPH According to an article published in the Archives of Internal Medicine, Dr Joseph Ross claimed a study conducted by Parke-Davis, before it was acquired by Pfizer, using gabapentin (Neurontin), as the drug under investigation, appeared to be a “seeding” trial. And while the author states that seeding …

Clinical Trial Ethics Read More »